SCHEMBL9525931

SCHEMBL9525931

CC(C)(C)[Si](OCCCCCc1ccccc1C=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMYD2 Q9NRG4 2/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CYP3A4 P08684 1/20 0.34
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
MEN1 O00255 1/20 0.31
RAD52 P43351 1/20 0.31
KMT2A Q03164 1/20 0.31
LTB4R Q15722 1/20 0.30
LTB4R2 Q9NPC1 1/20 0.30
LIPG Q9Y5X9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9529713 0.86 CDK4 (0.34) SMYD2HTTSMN1; SMN2CYP3A4PPARG
SCHEMBL9525868 0.85 SMYD2 (0.34) SMYD2HTTSMN1; SMN2CYP3A4PPARG
SCHEMBL7760793 0.84 TRAP1 (0.37) ALDH1A1
SCHEMBL9526961 0.83 PTGER4 (0.31) SMYD2HTTSMN1; SMN2CYP3A4PPARG
SCHEMBL19000267 0.82 CYP3A4 (0.33) SMYD2HTTSMN1; SMN2CYP3A4
SCHEMBL875044 0.81 BACE1 (0.39) SMYD2HTTSMN1; SMN2CYP3A4ALDH1A1
SCHEMBL9526923 0.81 SMYD2 (0.32) SMYD2HTTSMN1; SMN2CYP3A4
SCHEMBL9526204 0.81 SMYD2 (0.32) SMYD2HTTSMN1; SMN2CYP3A4
SCHEMBL9524689 0.81 BACE1 (0.30) PPARGPPARDPPARA
SCHEMBL9529914 0.81 CYP4F2 (0.41) SMYD2HTTSMN1; SMN2CYP3A4PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0419610-B1 NEW LEUKOTRIENE B4 DERIVATIVES, PROCESS FOR PRODUCING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1993-09-15 EP disclosed
EP-0419610-A1 NEW LEUKOTRIENE B4 DERIVATIVES, PROCESS FOR PRODUCING THEM AND THEIR USE AS DRUGS. SCHERING AG (DE) 1991-04-03 EP disclosed
WO-1990011271-A1 NEW LEUKOTRIENE B4 DERIVATIVES, PROCESS FOR PRODUCING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1990-10-04 WO disclosed